#IgAN is an active hashtag on Bluesky. In the last 30 days, 15 people shared 23 posts with it — around 1 a day. Activity is up 800% versus the previous week, peaking on Oct 22 with 7 posts.

Posts with #IgAN

Christos Argyropoulos MD, PhD, FASN 🇺🇸 0kale/acc

@christosargyrop.bsky.social

1 day ago

@hswapnil.medsky.social posted an interesting table about the cost effectiveness of drugs for #IgAN. lnkd.in/p/gSMwDiV4 These calculations were done and solidified years ago in the era of ARBs when losartan was considered too expensive to cover. #Nephrology #healthecon

lnkd.in

The cost and effect of IGA nephropathy redone Clarified that - last column is annual (US) cost - added a cost for Telitacicept (via Joel Topf ) Left is the simple version - right is a prettier… ...

The cost and effect of IGA nephropathy redone Clarified that - last column is annual (US) cost - added a cost for Telitacicept (via Joel Topf ) Left is the simple version - right is a prettier L...

1 2 3

@kireports.bsky.social

3 days ago

Clinical Trial of Open-Label #Mezagitamab in #IgAN: Final 96-Week Results #VisualAbstract by Brian Rifkin www.kireports.org/article…

0 0 2

Christos Argyropoulos MD, PhD, FASN 🇺🇸 0kale/acc

@christosargyrop.bsky.social

1 day ago

This does not mean that the drugs should not be used, but the price is not right for mass utilization, especially since we are finding perhaps more #IgAN since #COVID19 began. There is also the issue of long term side effects for some of these classes - an unknown unknown #Nephrology #healthecon

1 1 1

Christos Argyropoulos MD PhD

@christosargyrop.mastodon.social.ap.brid.gy

1 day ago

@hswapnil posted an interesting table about the cost effectiveness of drugs for #IgAN. lnkd.in/p/gSMwDiV4 These calculations were done and solidified years ago in the era of ARBs when losartan was considered too expensive to cover. #Nephrology #healthecon

www.linkedin.com

The cost and effect of IGA nephropathy redone Clarified that - last column is annual (US) cost - added a cost for Telitacicept (via Joel Topf ) Left is the simple version - right is a prettier… | Swapnil Hiremath

0 0 1

@seronda82.bsky.social

7 minutes ago

IGAN Generator Covers While Running for most 3500w-12000w Generators - Ultra Heavy Duty Generator Covers for Outside - Portable Waterproof Generator Cover, Generator Enclosure Outdoor Gray #waterproof #3500w-12000w #igan #generatorcover #protection

www.amazon.com

IGAN Generator Covers While Running for most 3500w-12000w Generators - Ultra Heavy Duty Generator Covers for Outside - Portable Waterproof Generator Cover, Generator Enclosure Outdoor Gray

0 0 0

Christos Argyropoulos MD, PhD, FASN 🇺🇸 0kale/acc

@christosargyrop.bsky.social

14 days ago

There should be no more placebo controlled trials in #IgAN. If you are developing a therapeutic design your trial as an add-on to an already approved therapy, as a rescue therapy or even better as an active comparator trial.

0 0 7

Jonathan Pollack

@jonathanpollack.bsky.social

15 days ago

Trying to keep this updated as best I can! What'd I miss? www.iganclarity.com/treat… #KidneyWk #IgANephropathy #IgAN #NephSky

0 0 0

Edgar V. Lerma 🇵🇭

@edgarvlermamd.medsky.network

17 days ago

Among patients w/ IgA nephropathy #IgAN, treatment w/ sibeprenlimab stabilized the eGFR slope over 24 months, consistent w/ a reduced risk of kidney-function decline ca. 2026 from @nejm.org #Nephpearls #KidneyWk #NephSky Visual Abstract by @cristinapopa.bsky.social 👉 www.nejm.org/doi/full/10....

0 0 2

ISNkidneycare

@theisn.org

17 days ago

📢 Now published: insights from the ISN International Expert Forum on complement therapeutics in C3G and IgAN. Explore the latest perspectives, knowledge gaps and priorities shaping complement-targeted therapies in these diseases. 📖 Read the paper: www.kidney-internati... #ThisIsISN #C3G #IgAN

1 0 2

Rolando Claure

@runningkidneys.bsky.social

18 days ago

🚨 Remarkable results from ORIGIN 3 in #IgAN! Atacicept reduced the risk of kidney disease progression by 76% at 104 weeks (HR 0.24; p<0.0001). ✅ 60% placebo-adjusted UPCR reduction ✅ Fewer serious adverse events (7% vs 15%) Promising kidney protection! #KidneyWk

0 0 5

Rolando Claure

@runningkidneys.bsky.social

18 days ago

🧬 TELIGAN Phase 3: telitacicept delivers sustained kidney protection in #IgAN! At 104 weeks: ✅ eGFR slope: −0.6 mL/min/1.73m²/year ✅ Proteinuria ↓60% from baseline ✅ Sustained reduction in Gd-IgA1 ✅ Favorable 2-year safety profile #KidneyWk

0 0 2

Rolando Claure

@runningkidneys.bsky.social

18 days ago

Impressive Phase 3 TELIGAN results in #IgAN! Telitacicept significantly slowed eGFR decline over 104 weeks: ✅ eGFR slope: −0.6 vs −5.7 mL/min/1.73m²/year ✅ Difference: +5.1 (P<0.001) ✅ 89% lower hazard of ≥30% eGFR decline (HR 0.11) #KidneyWk